Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2013
Innovating the future of molecular imaging.
Realizing the full potential of molecular imaging requires a new approach.
Siemens Molecular Imaging will once again demonstrate its innovation leadership at SNMMI 2013 by breaking through the boundaries defined by conventional PET/CT and SPECT/CT technologies, which could reinvent how molecular imaging is fundamentally performed.
Physicians expect diagnostic imaging to deliver definitive and timely answers to clinical questions, providing outcomes for improved patient health. And in an increasingly competitive and rapidly changing environment these answers must be defined as safely and efficiently as possible.
Siemens has always believed that even the farthest technical horizons were only temporary and could be surpassed with consistent dedication to improve healthcare. Now, once again, we will demonstrate our innovation leadership at SNMMI 2013 by breaking through boundaries defined by conventional technologies, reinventing how molecular imaging is fundamentally performed.
For the first time, you will be able to rely on molecular imaging results that could redefine clinical decision making. The information you need for potentially more diagnostic certainty and more informed treatment planning. With innovative solutions where the lowest dose can be used, while still scanning patients faster than ever before.
We invite you to visit us at SNMMI booth 720 to see the complete picture and experience why we are innovating the future of molecular imaging.